UK markets close in 22 minutes

BioLine Rx Ltd (YP2A.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.7135+0.1595 (+6.25%)
As of 03:42PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-60,614
-60,614
-24,951
-27,054
-30,021
-
Depreciation & amortisation
1,384
1,384
654
703
934
-
Stock-based compensation
2,321
2,321
2,245
1,495
1,272
-
Change in working capital
15,199
15,199
1,238
-540
-1,288
-
Accounts receivable
-358
-358
0
0
-
-
Inventory
-1,953
-1,953
0
0
-
-
Other working capital
-22,905
-22,905
-26,556
-23,670
-23,206
-
Other non-cash items
1,163
1,163
445
39
242
-
Net cash provided by operating activities
-22,608
-22,608
-26,240
-23,573
-23,206
-
Cash flows from investing activities
Investments in property, plant and equipment
-297
-297
-316
-97
-
-73
Acquisitions, net
-
-
-
-
-
0
Purchases of investments
-47,588
-47,588
-44,000
-78,000
-33,500
-
Sales/maturities of investments
49,329
49,329
48,322
39,873
50,168
-
Net cash used for investing activities
1,444
1,444
4,006
-38,224
16,668
-
Cash flows from financing activities
Debt repayment
-1,988
-1,988
-3,052
-3,572
-3,357
-
Common stock issued
14,089
14,089
14,359
50,407
19,246
-
Net cash used provided by (used for) financing activities
15,056
15,056
20,438
57,749
17,866
-
Net change in cash
-6,108
-6,108
-1,796
-4,048
11,328
-
Cash at beginning of period
10,587
10,587
12,990
16,831
5,297
-
Cash at end of period
4,255
4,255
10,587
12,990
16,831
-
Free cash flow
Operating cash flow
-22,608
-22,608
-26,240
-23,573
-23,206
-
Capital expenditure
-297
-297
-316
-97
-
-73
Free cash flow
-22,905
-22,905
-26,556
-23,670
-23,206
-